- Home
- Clinical Trials
COPD Studies Hawke's Bay 82
COPD Study
Hawke's Bay
Please note that this study has now closed. However, we encourage you to pre-register your interest for future COPD studies here.
Description
What to expect
Study details
Ages
40 to 75 years old
Duration
Up to 32 weeks, with 11 clinic visits
Compensation
You will be well compensated for any study related costs
Eligibility Criteria
You may qualify if you:
- Are between 40 and 75 years old
- Have been diagnosed with COPD for at least 12 months
- Are currently taking two or more daily inhaled COPD medications
- Are a former cigarette smoker
Other criteria apply. A member of our team will check if this study is a good fit for you.
Locations
Description
Chronic Obstructive Pulmonary Disease is a chronic lung condition that can make breathing difficult and reduce quality of life. Some people with COPD have a specific type of airway inflammation called Type 2 inflammation, which may make symptoms worse.
Common symptoms include shortness of breath, coughing, wheezing and fatigue. COPD affects over 300 million people globally and can significantly limit daily activities, social interactions, and overall quality of life. Though it develops gradually, its impact can be life changing.
Current COPD treatment aims to relieve symptoms, improve breathing, and prevent flare ups. These include inhalers, medications, pulmonary rehabilitation and in some cases, oxygen therapy.
This study is exploring a potential new treatment aimed at targeting a specific type of inflammation found in some people with COPD. By better understanding and treating this inflammatory pathway, researchers hope to improve breathing, slow disease progression, and enhance quality of life for those living with COPD.
What to expect
As a participant you will be randomly assigned to receive either:
· The investigational medication along with your usual COPD care
· A placebo along with your usual COPD care
The study medication (or placebo) will be given as a subcutaneous injection (under the skin) according to your assigned group. Depending on the group you are placed in, you will receive one injection every 4 weeks for the duration of the study.
You will visit the clinic regularly for health assessments, including lung function tests, symptoms check-ins, and general health monitoring. Throughout the study, our professional clinic team will closely monitor your well-being and provide support at every step.
Why join this clinical research study?
- Gain early access to new potential treatments at no cost
- Contribute to research for those living with COPD
- Receive study related health checks and advice from our professional medical team
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Study now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future COPD studies here.